Business Wire

CA-VERIMATRIX

1.9.2022 17:46:43 CEST | Business Wire | Press release

Share
Verimatrix to Showcase Game-Changing Cybersecurity Technology at IBC Conference

Regulatory News:

Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it will highlight its powerful content protection, anti-piracy and enterprise cybersecurity technologies for streaming services providers, broadcasters, telcos and operators from September 9-12 during this year’s IBC conference at RAI Amsterdam.

The company’s IBC showcase follows a fast-growing number of technology partnerships that underscore the appeal of the cloud-based Verimatrix Streamkeeper solution that’s designed to enable battle-ready, yet streamlined and cost-effective protections for content delivered via nearly any platform type. The IBC conference serves as one of the media and entertainment industry’s most notable venues to feature Verimatrix’s unique zero-code telemetry approach that makes anti-piracy and cybersecurity not only simple and fast, but also cost-effective and designed to encourage integration with other related M&E providers.

IBC Show Highlights:

- Product demos - Verimatrix XTD (Extended Threat Defense), Verimatrix Streamkeeper, Verimatrix Secure Delivery Platform and Verimatrix VCAS (IPTV/DVB)
- 3D hologram – A holographic presentation of Verimatrix Counterspy, the company’s proprietary anti-piracy and app protection security agent that uses proprietary zero code technology
- Partner recognition – Technology partners are critical to Verimatrix’s success, and the company will feature key partners on its partner wall, during demos and in booth videos

The company is set to host two in-booth mixers at its IBC Booth 1.C23 on September 9 and 10 with TiVo, a leader in DVR and advanced television, as well as The Goose House, a popular esports community that Verimatrix sponsors. Verimatrix is also sponsoring a Media and Entertainment Services Alliance (MESA) networking event scheduled for 8-10 p.m. on September 9 at Café Black.

“Today’s countless ways of delivering and consuming entertainment require a modern approach to anti-piracy and cyberattack prevention, but they must be offered as business enablers and value providers versus costs centers. Verimatrix Streamkeeper and Verimatrix XTD are two new solutions engineered to do just that,” said Asaf Ashkenazi, CEO at Verimatrix. “Our theme for IBC 2022 is ‘STREAM ON! Game changing security for streaming & beyond’ and we are excited to showcase a stunning new booth design where we will showcase our latest products alongside our award-winning, legacy content security solutions.”

Verimatrix Streamkeeper stands as a cybersecurity and anti-piracy gamechanger. Its users can implement a comprehensive set of content protection and anti-piracy solutions such as Multi-DRM, Watermarking, App Shield and other countermeasures that allow users to hunt down and take out OTT pirates who often take advantage of premium content that’s left unprotected. Streamkeeper includes Verimatrix's Counterspy technology – the autonomous injection of an anti-piracy and app protection security agent that uses proprietary zero code technology that brings deep, defensive countermeasures as well as the monitoring of clients without the hassle of a huge integration effort.

Verimatrix XTD defends against endpoint attacks by monitoring apps, APIs and unmanaged devices; illuminating blind spots and preventing firewall intrusions -- threats that are not typically covered by existing cybersecurity solutions.

Verimatrix Streamkeeper info is available at www.verimatrix.com/products/streamkeeper.
Verimatrix XTD info is available at www.verimatrix.com/products/extended-threat-defense.

About Verimatrix
Verimatrix (Euronext Paris: VMX) helps power the modern connected world with security made for people. We protect digital content, applications, and devices with intuitive, people-centered and frictionless security. Leading brands turn to Verimatrix to secure everything from premium movies and live streaming sports, to sensitive financial and healthcare data, to mission-critical mobile applications. We enable the trusted connections our customers depend on to deliver compelling content and experiences to millions of consumers around the world. Verimatrix helps partners get to market faster, scale easily, protect valuable revenue streams, and win new business. Visit www.verimatrix.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220901005488/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Datato Boehringer Ingelheim2.9.2026 14:00:00 CEST | Press release

Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp

Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 14:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o

Croma-Pharma Introduces Electronic Instructions for Use Across the saypha® Portfolio2.9.2026 13:37:00 CEST | Press release

Healthcare professionals in eligible markets can now access the Instructions for Use for the saypha® portfolio digitally by scanning a QR code on the product packaging Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructio

Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building2.9.2026 13:13:00 CEST | Press release

Orascom and Muriya press ahead across Hawana Salalah, Jebel Sifah and the US$90M+ As Sodah Island, signalling long-term conviction in Oman’s future, in step with Vision 2040. Across Oman, Orascom Development and its Sultanate platform, Muriya, are moving forward. While parts of the region grow cautious, Muriya has paused nothing, building and delivering across all three destinations: Hawana Salalah, Jebel Sifah and As Sodah Island. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902781576/en/ Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building (Photo: AETOSWire) The same steadiness runs through everything Samih Sawiris and Orascom have built, from El Gouna to Andermatt to Mamula Island: identifying extraordinary places and developing them for the long term. “Oman has everything we look for as a long-term developer: stability, natural beauty, and a clear direction for its future. Our continued investment

Aukera Closes €460 Million Structured Credit Facility Led by EIG to Support European Energy Infrastructure Portfolio2.9.2026 13:00:00 CEST | Press release

Aukera, the pan-European battery storage and renewable energy platform backed by AtlasInvest, Reggeborgh and SFPIM (Belgium's sovereign wealth fund), announced the closing of its €460 million structured credit facility, for which EIG, a leading institutional investor in the global energy and infrastructure sectors, served as the lead investor. With the financing in place, Aukera moves into its next phase of growth, combining capital, expertise and delivery capability to build a significant European energy infrastructure platform that develops, finances, constructs and operates assets at scale. The original facility included an initial €200 million commitment and an accordion feature of up to €250 million. The amended facility converts that accordion into a firmly committed €260 million Series 2 tranche, increasing total committed capital to €460 million. The additional capital will support the continued advancement of Aukera's portfolio of renewable energy generation, battery storage a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye